Publication | Open Access
Development of a Unique Small Molecule Modulator of CXCR4
130
Citations
43
References
2012
Year
We developed a novel small molecule, MSX-122, that is a partial CXCR4 antagonist without mobilizing stem cells, which can be safer for long-term blockade of metastasis than other reported CXCR4 antagonists.
| Year | Citations | |
|---|---|---|
Page 1
Page 1